Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology.

Autor: Conger RL; Department of Radiation Oncology, University of California-San Francisco, San Francisco, California., Mora J; Harvard Radiation Oncology Program, Boston, Massachusetts., Straza MW; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin., Erickson BA; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin., Lawton CAF; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin., Schultz CJ; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin., Currey A; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin., Bedi M; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin., Siker ML; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin., Hall WA; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Publikováno v: Advances in radiation oncology [Adv Radiat Oncol] 2023 Mar 02; Vol. 8 (4), pp. 101206. Date of Electronic Publication: 2023 Mar 02 (Print Publication: 2023).

Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer.

Autor: Crockett CB; Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, United Kingdom., Samson P; Department of Radiation Oncology, Washington University in St. Louis, St. Louis, MO, United States., Chuter R; Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom., Dubec M; Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom., Faivre-Finn C; Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom., Green OL; Department of Radiation Oncology, Washington University in St. Louis, St. Louis, MO, United States., Hackett SL; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands., McDonald F; Department of Radiotherapy, Royal Marsden NHS Foundation Trust, London, United Kingdom., Robinson C; Department of Radiation Oncology, Washington University in St. Louis, St. Louis, MO, United States., Shiarli AM; Department of Radiotherapy, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Straza MW; Department of Radiation Oncology, Froedtert and the Medical College of Wisconsin, Milwaukee, WI, United States., Verhoeff JJC; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands., Werner-Wasik M; Department of Radiation Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA, United States., Vlacich G; Department of Radiation Oncology, Washington University in St. Louis, St. Louis, MO, United States., Cobben D; Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.

Publikováno v: Frontiers in oncology [Front Oncol] 2021 Mar 10; Vol. 11, pp. 617681. Date of Electronic Publication: 2021 Mar 10 (Print Publication: 2021).

Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.

Autor: Hall WA; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States of America., Straza MW; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States of America., Chen X; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States of America., Mickevicius N; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States of America., Erickson B; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States of America., Schultz C; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States of America., Awan M; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States of America., Ahunbay E; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States of America., Li XA; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States of America., Paulson ES; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States of America.

Publikováno v: PloS one [PLoS One] 2020 Aug 07; Vol. 15 (8), pp. e0236570. Date of Electronic Publication: 2020 Aug 07 (Print Publication: 2020).

Therapeutic targeting of C-terminal binding protein in human cancer.

Autor: Straza MW; Department of Cancer Biology, University of Massachusetts Medical School and UMass Memorial Cancer Center, Worcester, MA, USA., Paliwal S, Kovi RC, Rajeshkumar B, Trenh P, Parker D, Whalen GF, Lyle S, Schiffer CA, Grossman SR

Publikováno v: Cell cycle (Georgetown, Tex.) [Cell Cycle] 2010 Sep 15; Vol. 9 (18), pp. 3740-50. Date of Electronic Publication: 2010 Sep 08.